Integrin 3D structures
From Proteopedia
(Difference between revisions)
(New page: ==3D structures of integrin== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *IG CR3 **1ido – hIG I domain ...) |
|||
Line 32: | Line 32: | ||
**[[3hi6]] - hIG I domain (mutant) + antibody + Mn<br /> | **[[3hi6]] - hIG I domain (mutant) + antibody + Mn<br /> | ||
- | *IG CD11b | + | *IG CD11b I domain 143-337 or IG α-M |
- | **[[1bho]] - hIG | + | **[[1idn]], [[1na5]] - hIG<br /> |
- | **[[1bhq]] - hIG | + | **[[1mf7]] - hIG (mutant)<br /> |
- | **[[1m1u]] - hIG | + | **[[1bho]] - hIG + Mg<br /> |
- | **[[1n9z]] - hIG | + | **[[1bhq]] - hIG + Cd<br /> |
- | **[[ | + | **[[1m1u]] - hIG (mutant) + Ca<br /> |
- | **[[ | + | **[[1n9z]] - hIG (mutant) + Mg<br /> |
+ | **[[3q3g]], [[3qa3]] – hIG + antibody<br /> | ||
+ | **[[4m76]] – hIG + complement C3<br /> | ||
+ | **[[2lke]], [[2lkj – hIG cytoplasmic domain – NMR<br /> | ||
+ | **[[4xw2]] – hIG + simvastatin<br /> | ||
+ | **[[6rhv]], [[6rhw]] – hIG + cytolysin<br /> | ||
*IG CD11c | *IG CD11c | ||
Line 47: | Line 52: | ||
*IG α-1 (CD49a) | *IG α-1 (CD49a) | ||
- | **[[1ck4]] - rIG I domain – rat<br /> | ||
**[[4a0q]] - hIG I domain (mutant) + Mg<br /> | **[[4a0q]] - hIG I domain (mutant) + Mg<br /> | ||
**[[2l8s]] - hIG transmembrane domain – NMR<BR /> | **[[2l8s]] - hIG transmembrane domain – NMR<BR /> | ||
**[[5hgj]] - hIG VWFA domain<br /> | **[[5hgj]] - hIG VWFA domain<br /> | ||
+ | **[[2m32]] - hIG I domain + collagen peptide<br /> | ||
+ | **[[1ck4]] - rIG I domain – rat<br /> | ||
**[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | **[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | ||
**[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | **[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | ||
- | **[[2m32]] - hIG I domain + collagen peptide<br /> | ||
*IG α-2 (CD49b) | *IG α-2 (CD49b) | ||
Line 89: | Line 94: | ||
**[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | **[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | ||
**[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | **[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | ||
+ | **[[6v4p]] – hIG + antibody – Cryo-EM<br /> | ||
*IG α-4 | *IG α-4 | ||
Line 132: | Line 138: | ||
**[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | **[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | ||
- | *IG α- | + | *IG α-V β-3 |
- | **[[ | + | **[[6mk0]] – hIG + antagonist<br /> |
- | **[[ | + | **[[6msl]] – hIG + cysteine knot protein<br /> |
- | **[[ | + | **[[6msu]] – hIG + EETI-II<br /> |
- | **[[ | + | **[[6naj]] – hIG + fibronectin<br /> |
*IG α-V β-8 | *IG α-V β-8 | ||
- | **[[6djp]] – hIG + antibody – Cryo EM<br /> | + | **[[6djp]], [[6ujb]], [[6ujc]] – hIG + antibody – Cryo EM<br /> |
+ | **[[6om1]] – hIG (mutant)<br /> | ||
+ | **[[6om2]] – hIG (mutant) + Protgf-b1 RGD peptide<br /> | ||
+ | **[[6uja]] – hIG + Protgf-b1 RGD – Cryo EM<br /> | ||
*IG α-X | *IG α-X |
Revision as of 08:49, 25 August 2020
3D structures of integrin
Updated on 25-August-2020 {{#tree:id=OrganizedByTopic|openlevels=0|
- IG CR3
- IG CD11a or IG α-L
- IG CD11a complexes
- 1cqp - hIG I domain + lovastatin + Mg
- 1mq8, 3bn3, 3tcx - hIG I domain (mutant) + intracellular adhesion molecule + Mg
- 1t0p - hIG I domain + intracellular adhesion molecule-3 + Mg
- 1rd4, 2ica, 3bqm, 3bqn, 3e2m - hIG I domain + inhibitor
- 2o7n, 3m6f - hIG I domain + antagonist
- 1xdd, 1xdg, 1xuo - hIG I domain + inhibitor + Mg
- 4ixd - hIG I domain + activator + Mg
- 3f78 - hIG I domain + anesthetic + Mg
- 3eoa, 3eob - hIG I domain + antibody
- 3hi6 - hIG I domain (mutant) + antibody + Mn
- 1cqp - hIG I domain + lovastatin + Mg
- IG CD11b I domain 143-337 or IG α-M
- IG CD11c
- 1n3y - hIG I domain (mutant)
- IG α-1 (CD49a)
- IG α-2 (CD49b)
- IG α-2b
- 2k1a - hIG transmembrane domain – NMR
- 2k1a - hIG transmembrane domain – NMR
- IG α-1 β-1 (CD49a-CD49b)
- IG α-2 (CD49b) β
- IG α-2b β-3 (CD61)
- 1kup, 1kuz – hIG proximal domain – NMR
- 1m8o - hIG cytoplasmic domain – NMR
- 4cak – hIG – Cryo-EM
- 2k9j, 2knc - hIG transmembrane domain – NMR
- 1tye, 3fcu, 3fcs – hIG + Mg
- 3fc3 – hIG (mutant) + Mg
- 2vc2, 2vdk, 2vdl, 3nid, 3nif, 3nig, 3zdx, 3zdy, 3zdz, 3ze0, 3ze1, 3ze2, 5hdb – hIG headpiece + antibody + Mg
- 4z7q, 4z7o, 4z7n – hIG headpiece + antibody + Mg + tetrapeptide
- 2vdm, 2vdn, 3t3m, 3t3p – hIG headpiece + antibody + antagonist + Mg
- 2vdo, 2vdp, 2vdq, 2vdr – hIG headpiece + antibody + fibrinogen peptide + Mg
- 6v4p – hIG + antibody – Cryo-EM
- 1kup, 1kuz – hIG proximal domain – NMR
- IG α-4
- 4irz - hIG + antibody
- 4irz - hIG + antibody
- IG α-4 (CD49d) β-7
- IG α-5 (CD49e) β-1 (CD29)
- IG α-5 (CD49e) β-3 (CD61) ectodomain
- IG α-5 β-6
- IG α-L
- IG α-L β-2
- 5e6u – hIG headpiece (mutant) + Ni
- 5e6u – hIG headpiece (mutant) + Ni
- IG α-V β-3
- IG α-V β-8
- IG α-X
- 2luv – hIG cytoplasmic domain – NMR
- 2luv – hIG cytoplasmic domain – NMR
- IG α-X β-2 (CD18)
- IG β-1D
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- IG β-2 (CD18)
- IG β-3 (CD61)
- IG β-4 (CD104; Gp150)
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- 2yrz – hIG fibronectin type III domain – NMR
- 3f7p, 4q58 - hIG fibronectin type III domain + plectin-1
- 6gvl - hIG fibronectin type III domain + dystonin
- 6gvk - hIG fibronectin type III domain (mutant) + dystonin
- 3fq4, 3fso, 3h6a – hIG Calx-β domain
- 6hyf - rIG fibronectin type III domain
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- IG β-7
}}